Diabetes Mellitus Standards Flashcards
7 cards from real NRCME practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Diabetes Mellitus Standards flashcards as text
The FMCSA Federal Diabetes Exemption Program requires that an insulin-treated applicant be evaluated by:
Answer: An endocrinologist or primary care physician familiar with their diabetes management
The treating endocrinologist or knowledgeable primary care physician must complete the required attestation forms.
A driver with diabetes has a resting blood pressure of 160/100 mmHg at the examination. The examiner should:
Answer: Address hypertension per FMCSA standards, as comorbidities compound cardiovascular risk
Hypertension and diabetes together significantly elevate cardiovascular risk and must both be evaluated under FMCSA standards.
What is the minimum pre-driving blood glucose level recommended for insulin-treated exempt CMV drivers before operating a CMV?
Answer: 100 mg/dL
Insulin-treated exempt drivers are generally advised to confirm blood glucose is at least 100 mg/dL before driving.
A CMV driver with diabetes develops diabetic nephropathy with creatinine of 3.5 mg/dL. The primary concern for certification is:
Answer: Cardiovascular risk and potential for uremic symptoms impairing alertness
Severely reduced kidney function elevates cardiovascular risk and may cause uremic symptoms that impair driving ability.
Which piece of documentation is NOT typically required for the Federal Diabetes Exemption Program application?
Answer: Proof of automobile liability insurance
The exemption program requires medical and glycemic control documentation, not personal automobile insurance.
How often must insulin-treated CMV drivers under the diabetes exemption check blood glucose when driving long hauls?
Answer: Every 4 hours and within 1 hour before driving
FMCSA exemption guidelines typically require checks every 4 hours and within 1 hour before beginning to drive.
Which type of diabetes medication carries the LOWEST risk of hypoglycemia relevant to FMCSA driving safety?
Answer: Sitagliptin (DPP-4 inhibitor)
DPP-4 inhibitors work glucose-dependently and have a very low intrinsic risk of causing hypoglycemia.